These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2683025)

  • 21. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cellular and molecular mechanisms of the gastric mucosa: injury of the mucosa and the protective action of antacids].
    Tarnawski A
    Rev Gastroenterol Peru; 1995; 15(1):74-8. PubMed ID: 7537548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroduodenal mucosal defense.
    deFoneska A; Kaunitz JD
    Curr Opin Gastroenterol; 2010 Nov; 26(6):604-10. PubMed ID: 20948371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of the gastroduodenal mucosa by prostaglandins.
    Johansson C; Aly A; Befrits R; Smedfors B; Uribe A
    Scand J Gastroenterol Suppl; 1985; 110():41-8. PubMed ID: 3895394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nonsteroidal antiinflammatory drugs on gastric and duodenal mucosa.
    Moghal N; Jafarey NA
    Gastroenterology; 1989 Feb; 96(2 Pt 1):553-4. PubMed ID: 2910767
    [No Abstract]   [Full Text] [Related]  

  • 26. Some new aspects of gastric mucosal protection and damage.
    Bennett A
    Acta Physiol Hung; 1989; 73(2-3):179-83. PubMed ID: 2688358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gastric mucosal epithelial barrier: role of mucus and fibrin.
    Allen A; Sellers LA; Bennett MK
    Scand J Gastroenterol Suppl; 1987; 128():6-13. PubMed ID: 3306901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric mucosal defence mechanisms: a brief review.
    Forssell H
    Scand J Gastroenterol Suppl; 1988; 155():23-8. PubMed ID: 3072665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs.
    Wooten JG; Blikslager AT; Ryan KA; Marks SL; Law JM; Lascelles BD
    Am J Vet Res; 2008 Apr; 69(4):457-64. PubMed ID: 18380576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biochemical protective mechanisms against non-steroidal anti-inflammatory drug induced G-I mucosal damage.
    Rainsford KD
    Acta Physiol Hung; 1989; 73(2-3):261-78. PubMed ID: 2512767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current concepts of gastroduodenal mucosal protection.
    Garner A; Flemström G; Allen A
    Scand J Gastroenterol Suppl; 1984; 92():78-80. PubMed ID: 6429845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
    Cryer B; Feldman M
    Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandins--role in gastric mucosal cytoprotection.
    Sewell RB
    Med J Aust; 1985 Feb; 142 Spec No():S10-3. PubMed ID: 3937961
    [No Abstract]   [Full Text] [Related]  

  • 34. [The availability of prostaglandin derivatives in a treatment and prevention for gastrointestinal mucosal injury].
    Harada S; Takeuchi T; Edogawa S; Ota K; Kojima Y; Higuchi K
    Nihon Rinsho; 2015 Jul; 73(7):1153-8. PubMed ID: 26165072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective Factors of the Gastric and Duodenal Mucosa: An Overview.
    Yandrapu H; Sarosiek J
    Curr Gastroenterol Rep; 2015 Jun; 17(6):24. PubMed ID: 26109006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A histological study of the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the gastric and duodenal mucosa.
    Moghal N; Jafarey NA
    J Pak Med Assoc; 1989 Nov; 39(11):287-90. PubMed ID: 2516535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandins: mucosal protection and peptic ulceration.
    Hawkey CJ
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():45-51. PubMed ID: 2657288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric and duodenal mucosal blood flow in patients receiving non-steroidal anti-inflammatory drugs--influence of age, smoking, ulceration and Helicobacter pylori.
    Taha AS; Angerson W; Nakshabendi I; Beekman H; Morran C; Sturrock RD; Russell RI
    Aliment Pharmacol Ther; 1993 Feb; 7(1):41-5. PubMed ID: 8439636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Rainsford KD
    Scand J Gastroenterol Suppl; 1989; 163():9-16. PubMed ID: 2683030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.